Intec Parent is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, which Co. refers to as the Accordion Pill. Co.'s primary product candidate, Accordion Pill Carbidopa/Levodopa is being developed for the indication of treatment of Parkinson's disease symptoms in Parkinson's disease patients. In addition, Co. has initiated a clinical development program for its Accordion Pill platform with the two primary cannabinoids contained in cannabis sativa, which it refers to as AP-Cannabinoids. Co. is formulating and testing Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. We show 16 historical shares outstanding datapoints in our NTEC shares outstanding history coverage, used to compute NTEC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NTEC market cap history over the course of time is important for investors
interested in comparing NTEC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NTEC versus a peer is one thing; comparing
NTEC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NTEC can fluctuate over the course of history.
With this page we aim to empower investors researching NTEC by allowing them to research the NTEC market cap history. |
Free NTEC Email Alerts:
Video: The Importance of Market Cap
